Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tarín, J.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tarín, J.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. 1, pp. 165-170, 1995
© 1995 European Society of Human Reproduction and Embryology

Subzonal insemination, partial zona dissection or intracytoplasmic sperm injection? An easy decision?

J.J. Tarín

Department of Paediatrics, Obstetrics, and Gynaecology, Faculty of Medicine, University of Valencia Avda. Blasco Ibanez 17, Valencia 46010, Spain

This review aims to analyse and compare the results to date of subzonal insemination (SUZI), partial zona dissection (PZD) and intracytoplasmic sperm injection (ICSI) to evaluate critically whether it is now possible to replace SUZI and PZD by ICSI. It appears that ICSI is a much more efficient assisted reproduction technique than SUZI and PZD for resolving cases of severe male infertility and/or repeated failure of conventional in-vitro fertilization (IVF). For ICSI compared with SUZI and PZD, fertilization (49.4, 17.7 and 16.8% respectively), percentage of patients reaching embryo transfer (91.0, 55.1 and 23.3% respectively), percentage of transfers performed with two or three embryos (83.3% ICSI and 39.3% SUZI), pregnancy rate per embryo replacement (28.2, 18.7 and 16.5% respectively) and pregnancy rate per oocyte retrieval (24.8, 10.3 and 3.8% respectively) are all improved. In addition, cases of severely impaired semen characteristics, which were condemned to infertility for life with conventional IVF, SUZI or PZD, can now be treated and resolved efficiently with ICSI.

Key words: intracytoplasmic sperm injection/partial zona dissection/subzonal insemination

Submitted on April 13, 1994; accepted on September 7, 1994.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
G. Griesinger, E.M. Kolibianakis, K. Diedrich, and M. Ludwig
Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study
Hum. Reprod., November 1, 2008; 23(11): 2549 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Popovic-Todorovic, A. Loft, A. Lindhard, S. Bangsboll, A.M. Andersson, and A.N. Andersen
A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram
Hum. Reprod., April 1, 2003; 18(4): 781 - 787.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. de La Rochebrochard and P. Thonneau
Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study
Hum. Reprod., June 1, 2002; 17(6): 1649 - 1656.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.H. Check, C. Dietterich, D. Lurie, and A. Nazari
No evidence of increased uterine vascular impedance with patient ageing following IVF
Hum. Reprod., August 1, 2000; 15(8): 1679 - 1684.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. M. Pitkin
Obstetrics and Gynecology
JAMA, June 19, 1996; 275(23): 1829 - 1830.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.